180 related articles for article (PubMed ID: 38317799)
1. How to address vaccine hesitancy? Lessons from National Hepatitis B Immunization Program in China.
Jiang H; Wei C
Front Public Health; 2024; 12():1286801. PubMed ID: 38317799
[TBL] [Abstract][Full Text] [Related]
2. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
[TBL] [Abstract][Full Text] [Related]
3. [Hesitancy of parents towards vaccines in national immunization program in three regions in China: a cross-sectional study].
Zhao TS; Liu HY; Zheng H; Han BF; Liu B; Liu J; Zhao CY; Li XJ; Yang SB; Du J; Huang NH; Lu QB; Liu YQ; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Sep; 42(9):1615-1620. PubMed ID: 34814592
[No Abstract] [Full Text] [Related]
4. Increasing Coverage of Hepatitis B Vaccination in China: A Systematic Review of Interventions and Implementation Experiences.
Wang S; Smith H; Peng Z; Xu B; Wang W
Medicine (Baltimore); 2016 May; 95(19):e3693. PubMed ID: 27175710
[TBL] [Abstract][Full Text] [Related]
5. Impact of the national hepatitis B immunization program in China: a modeling study.
Liu Z; Li M; Hutton DW; Wagner AL; Yao Y; Zhu W; Cao L; Tang S; Pan J; Wang Y; Zhao Q; Ren H; Wang Y; Wang W
Infect Dis Poverty; 2022 Oct; 11(1):106. PubMed ID: 36221140
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
Yu W; Lee LA; Liu Y; Scherpbier RW; Wen N; Zhang G; Zhu X; Ning G; Wang F; Li Y; Hao L; Zhang X; Wang H
Vaccine; 2018 Dec; 36(52):8131-8137. PubMed ID: 30497834
[TBL] [Abstract][Full Text] [Related]
7. Developing an effective and sustainable national immunisation programme in China: issues and challenges.
Chen S; Yao L; Wang W; Tang S
Lancet Public Health; 2022 Dec; 7(12):e1064-e1072. PubMed ID: 36252582
[TBL] [Abstract][Full Text] [Related]
8. Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021.
Liu X; Yu W; Yin Z; Rodewald L; Song Y; Zhang Z; Ye J; Li L; Cao L; Cao L
Vaccine; 2022 Apr; 40(18):2561-2567. PubMed ID: 35339307
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F
Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678
[TBL] [Abstract][Full Text] [Related]
10. Integration of hepatitis B immunization in the Expanded Program on Immunization of the Child Survival Project.
Mansour E; Abdul-Rahim S; Batouty G; Zaghloul I; Abdel-Hadi S
J Egypt Public Health Assoc; 1993; 68(5-6):487-94. PubMed ID: 7775876
[TBL] [Abstract][Full Text] [Related]
11. Countdown to 2030: eliminating hepatitis B disease, China.
Liu J; Liang W; Jing W; Liu M
Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
[TBL] [Abstract][Full Text] [Related]
12. Impact evaluation of the routine hepatitis B vaccination program of infants in China.
Sun M; Li C; Li P; Lu J; Wang Y; Chang F; Li X; Hao M
J Public Health (Oxf); 2019 Mar; 41(1):158-163. PubMed ID: 29385505
[TBL] [Abstract][Full Text] [Related]
13. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study.
Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y
Front Immunol; 2021; 12():781161. PubMed ID: 34912346
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B vaccination in Iran: Historical policies and programs.
Behzadifar M; Azari S; Shirkhani S; Gholamrezaei S; Shahabi S; Doshmangir L; Ehsanzadeh SJ; Martini M; Bragazzi NL; Behzadifar M
J Prev Med Hyg; 2022 Dec; 63(4):E618-E624. PubMed ID: 36891002
[TBL] [Abstract][Full Text] [Related]
16. An assessment of hepatitis B vaccine introduction in India: Lessons for roll out and scale up of new vaccines in immunization programs.
Lahariya C; Subramanya BP; Sosler S
Indian J Public Health; 2013; 57(1):8-14. PubMed ID: 23649136
[TBL] [Abstract][Full Text] [Related]
17. An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration.
Gidudu JF; Shaum A; Habersaat K; Wilhelm E; Woodring J; Mast E; Zuber P; Amarasinghe A; Nelson N; Kabore H; Abad N; Tohme RA
Vaccine; 2020 Nov; 38(49):7728-7740. PubMed ID: 31337590
[TBL] [Abstract][Full Text] [Related]
18. From Cannes 1993 to the present.
Van Damme P; Verwimp G
Vaccine; 1998 Nov; 16 Suppl():S3-6. PubMed ID: 9915024
[TBL] [Abstract][Full Text] [Related]
19. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
Luo Z; Li L; Ruan B
Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658
[TBL] [Abstract][Full Text] [Related]
20. Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.
Dai P; Wang Q; Jia M; Leng Z; Xie S; Feng L; Yang W
Hum Vaccin Immunother; 2023 Dec; 19(1):2194190. PubMed ID: 37099400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
